Cancer News and Research

Latest Cancer News and Research

Brain function variations may increase person's risk of drug abuse

One can look at drug addiction as a moral issue, a social ill, or a criminal problem. But Lynn Oswald's experience studying the neuroscience of addiction tells her that it is something else entirely: a disease of the brain.

30 Apr 2011

Opinions: NCDs must be tackled worldwide; myths surround usefulness of foreign aid

Jake Marcus, a post-bachelor fellow at the Institute for Health Metrics and Evaluation, examines why non-communicable diseases have been a neglected part of global health care in a New Republic opinion piece.

30 Apr 2011

Healthcare advertising agencies earn Med Ad News recognition

UBM Canon has announced the winners of the 22nd annual Med Ad News Manny Awards 2011. The gala event, held at the Sheraton New York Hotel and Towers, culminated with the naming of AbelsonTaylor Inc. as Agency of the Year: Category I.

30 Apr 2011

ATRN experts to improve health in Appalachian region

According to the Centers for Disease Control and Prevention, residents of many Appalachian counties are three times more likely to die from diabetes than someone living in other counties in the same state, or in most other parts of the United States. Now, a group of seven regional academic centers and community organizations have joined forces to change those health disparities and improve health through the creation of the Appalachian Translational Research Network.

30 Apr 2011

University of South Florida researcher earns Everfront Award for stem cell study

Dr. Paul Sanberg, Distinguished University Professor and senior associate vice president for research and innovation at the University of South Florida, received the Everfront Award at the 4th Pan Pacific Symposium on Stem Cell and Cancer Research held earlier this month in Taichung, Taiwan.

30 Apr 2011

Keryx Biopharmaceuticals reports net loss of $6.4 million for first quarter 2011

Keryx Biopharmaceuticals, Inc., a biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of cancer and renal disease, today announced its results for the first quarter ended March 31, 2011.

30 Apr 2011

New guide to help cancer patients manage symptoms, side effects

Cancer patients can be hit with a nasty array of symptoms and side effects, from anemia and anxiety to hair loss and hot flashes. Some of these problems can be so overwhelming that they cause patients to abandon life-saving treatments.

30 Apr 2011

IMPAKT 2011 conference to highlight new breast cancer studies

"The presentations at this year's IMPAKT reveal the innovative and diverse approaches that investigators are taking to identify the most encouraging new agents both before clinical evaluation and in early clinical studies. These range from ideas for novel clinical designs to the development of more sensitive and specific biomarkers and to data sharing that allows a more objective assessment of compounds prior to commitment of major clinical resources."

30 Apr 2011

CEL-SCI receives no objection letter to initiate Phase III clinical trial of Multikine in Canada

CEL-SCI Corporation announced today that the Biologics and Genetic Therapeutics Directorate of Health Canada has issued a final "no objection" letter for CEL-SCI to be able to begin enrollment of patients for a Phase III clinical trial of Multikine in Canada.

30 Apr 2011

FDA approves Abbott's AndroGel for hypogonadism treatment in men

Abbott announced today that the U.S. Food and Drug Administration has approved AndroGel 1.62%, a clear, odorless, gel formulation shown to restore testosterone levels in hypogonadal men with half the volume of gel at the starting dose compared to AndroGel 1%.

30 Apr 2011

Spectrum receives FDA approval for FUSILEV to treat colorectal cancer

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, received approval from the U.S. Food and Drug Administration on April 29, 2011, for the use of FUSILEV in combination with 5-fluorouracil in the palliative treatment of patients with advanced metastatic colorectal cancer.

30 Apr 2011

Reimbursement policy influences choice of IMRT for treating breast cancer

What Medicare would pay for and where a radiation oncologist practiced were two factors that strongly influenced the choice of intensity-modulated radiation therapy (IMRT) for treating breast cancer, according to an article published April 29 online in the Journal of the National Cancer Institute. The use of IMRT and the cost of radiation therapy increased sharply over the period of the study.

29 Apr 2011

Oncothyreon prices underwritten public offering of common stock

Oncothyreon Inc. today announced that it has priced an underwritten public offering of 10,000,000 shares of its common stock at a price to the public of $4.00 per share for gross proceeds of $40.0 million. The net proceeds from the sale of the shares, after deducting the underwriters' discounts and other estimated offering expenses payable by Oncothyreon, will be approximately $37.4 million.

29 Apr 2011

Annual mammogram sufficient follow-up after BCT for breast cancer patients

An annual mammogram is sufficient follow-up after breast conserving therapy (BCT) for breast cancer patients, according to a study presented today, at the Cancer Imaging and Radiation Therapy Symposium in Atlanta. This symposium is co-sponsored by the American Society for Radiation Oncology (ASTRO) and Radiological Society of North America (RSNA).

29 Apr 2011

Proton radiography imaging helps lower radiation dosage to pediatric cancer patients

Proton radiography imaging used prior to and during proton treatments for pediatric cancer patients provides for more accurate treatment delivery and a lower dose of radiation compared to standard diagnostic X-rays and cone beam CT, according to a study presented today at the Cancer Imaging and Radiation Therapy Symposium in Atlanta. The symposium is co-sponsored by the American Society for Radiation Oncology (ASTRO) and the Radiological Society of North America (RSNA).

29 Apr 2011

Pelvic MRI scan identifies local recurrence of prostate cancer at low PSA levels

A pelvic MRI scan with IV contrast and rectal balloon is highly effective in identifying local recurrence even at low PSA values in prostate cancer patients with a rising or persistently elevated PSA after prostatectomy, according to a study presented April 29, 2011, at the Cancer Imaging and Radiation Therapy Symposium in Atlanta. The symposium is co-sponsored by the American Society for Radiation Oncology (ASTRO) and the Radiological Society of North America (RSNA).

29 Apr 2011

Injecting tissue spacers reduces risk of radiation burns to rectum in prostate cancer patients

Injecting a tissue spacer in the prostate-rectal inter-space is an effective way to reduce the rectal dose for prostate cancer patients receiving radiation therapy, according to research presented April 30, 2011, at the Cancer Imaging and Radiation Therapy Symposium in Atlanta. This symposium is sponsored by the American Society for Radiation Oncology (ASTRO) and Radiological Society of North America (RSNA).

29 Apr 2011

Interval training and healthy eating are perfect solutions for obesity sufferers

A program which combines interval training and healthy eating practices seems to be perfectly indicated for those suffering from obesity, according to the results of a new study from the Montreal Hearth Institute's centre for preventive medicine and physical activity.

29 Apr 2011

Antiviral Drugs Advisory Committee recommends FDA to approve telaprevir for hepatitis C

Vertex Pharmaceuticals Incorporated announced that the Antiviral Drugs Advisory Committee to the U.S. Food and Drug Administration voted unanimously to recommend FDA approval of telaprevir for people with genotype 1 chronic hepatitis C.

29 Apr 2011

Scientists develop novel genetic model of premature aging disorders

Working with a group of national and international researchers, scientists from the Florida campus of The Scripps Research Institute have developed a new genetic model of premature aging disorders that could shed light on these rare conditions in humans and provide a novel platform for large-scale screening of compounds to combat these and other age-related diseases.

29 Apr 2011

Cancer News and Research

Latest Cancer News and Research

Brain function variations may increase person's risk of drug abuse

Opinions: NCDs must be tackled worldwide; myths surround usefulness of foreign aid

Healthcare advertising agencies earn Med Ad News recognition

ATRN experts to improve health in Appalachian region

University of South Florida researcher earns Everfront Award for stem cell study

Keryx Biopharmaceuticals reports net loss of $6.4 million for first quarter 2011

New guide to help cancer patients manage symptoms, side effects

IMPAKT 2011 conference to highlight new breast cancer studies

CEL-SCI receives no objection letter to initiate Phase III clinical trial of Multikine in Canada

FDA approves Abbott's AndroGel for hypogonadism treatment in men

Spectrum receives FDA approval for FUSILEV to treat colorectal cancer

Reimbursement policy influences choice of IMRT for treating breast cancer

Oncothyreon prices underwritten public offering of common stock

Annual mammogram sufficient follow-up after BCT for breast cancer patients

Proton radiography imaging helps lower radiation dosage to pediatric cancer patients

Pelvic MRI scan identifies local recurrence of prostate cancer at low PSA levels

Injecting tissue spacers reduces risk of radiation burns to rectum in prostate cancer patients

Interval training and healthy eating are perfect solutions for obesity sufferers

Antiviral Drugs Advisory Committee recommends FDA to approve telaprevir for hepatitis C

Scientists develop novel genetic model of premature aging disorders

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in